Skip to main content

Table 1 Characteristics of the subjects in both groups at initial visit (before taking drugs)

From: LDL-cholesterol lowering effect of a generic product of simvastatin compared to simvastatin (Zocor™) in Thai hypercholesterolemic subjects – a randomized crossover study, the first report from Thailand

Parameters

mean ± standard deviation (90 % confidence interval)

P-value

 

1st group (N = 22)

2nd group (N = 21)

 

Age (years)

48.90 ± 10.83

48.45 ± 9.36

NS

 

(45.01–52.79)

(45.17–51.73)

 

Total cholesterol (mg/dL)

259.30 ± 31.83

254.40 ± 33.47

NS

 

(247.87–270.73)

(242.66–266.14)

 

HDL (mg/dL)

45.50 ± 12.27

44.80 ± 10.04

NS

 

(41.10–49.90)

(41.28–43.32)

 

Triglyceride (mg/dL)

160.00 ± 90.71

168.40 ± 89.23

NS

 

(127.44–192.56)

(137.11–199.69)

 

LDL (mg/dL)

181.90 ± 25.33

175.90 ± 30.71

NS

 

(172.81–190.99)

(165.13–186.67)

 

Sgot (U/L)

26.40 ± 10.33

24.50 ± 8.38

NS

 

(22.69–30.11)

(21.56–27.44)

 

Sgpt (U/L)

30.00 ± 15.26

31.30 ± 20.95

NS

 

(24.52–35.48)

(23.95–38.65)

 

CPK (U/L)

123.80 ± 68.94

125.70 ± 73.54

NS

 

(99.05–148.55)

(99.91–151.49)